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Abstract
Sarcoidosis is a multisystem granulomatous disease commonly involving the lungs and mediastinal lymph nodes with the
exact etiology being unclear. The simultaneous presence of malignant disease such as breast cancer and sarcoidosis has been
reported. Sarcoidosis preceding a diagnosis of malignancy and that occurring years after treatment of malignant disease has
been noted in the past. The presence of sarcoidosis in the setting of malignant disease carries a high risk of misdiagnosis. In this
article, we report the case of a 45-year-old female with stage IA invasive ductal carcinoma of left breast that was in remission
for 2 years; however, radiological imaging including magnetic resonance imaging of thoracic spine and positron emission
tomography–computed tomography scanning were highly suspicious for malignant disease metastasis versus lymphoma with
the widespread lymphadenopathy. Multiple tissue biopsies with histopathological evaluation allowed us to definitively exclude
malignant disease metastasis and to correctly diagnose her atypical presentation of sarcoidosis.
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Sarcoidosis is a chronic systemic granulomatous disease of
unknown etiology. Characteristic histological finding in sarcoidosis includes the presence of nonspecific, noncaseating
granulomas.1-3 Increased incidence of sarcoidosis has been
noted in females, African American race, and patients aged
20 to 40 years. Clinical presentation of sarcoidosis is variable according to the stage of the disease and degree of organ
involvement; patients may be asymptomatic or may have
varied clinical features (Table 1).3-6 Frequently, patients may
have pulmonary manifestations, constitutional symptoms,
visual disturbances, hepatosplenomegaly, peripheral adenopathy, dermatologic manifestations with arthralgias, and neurologic manifestations.3,4,7
Sarcoidosis is often a diagnosis of exclusion. More than
90% of patients will have pulmonary involvement. Skin
involvement occurs in about 25% of patients, and erythema
nodosum is a common dermatologic manifestation.4,7,8
Erythema nodosum in sarcoidosis usually represents panniculitis and should not be biopsied to confirm a diagnosis of
sarcoidosis. Diagnosis of sarcoidosis requires suggestive
clinical, radiological findings along with exclusion of other
conditions that present similarly and a tissue biopsy showing
noncaseating granulomas.3,4,7,8

Table 1. Clinical Presentation of Sarcoidosis.1,3,5,6,7,16
1. Respiratory system: cough, dyspnea, chest discomfort, and
nonproductive cough
2. Constitutional symptoms: fatigue, weight loss, malaise, and
anorexia
3. Skin involvement: erythema nodosum, macules, papules,
subcutaneous nodules, and hyperpigmentation
4. Ocular symptoms: conjunctivitis, uveitis, iritis, and blurred
vision
5. Hepatosplenomegaly, peripheral lymphadenopathy
6. Myocardial involvement: cardiomyopathy, arrhythmias
7. Arthralgias can be seen in about 40% of cases
8. Neurological symptoms: meningeal involvement,
hypothalamic and pituitary lesions, and diabetes insipidus
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Case Presentation
A 45-year-old female with a past medical history of stage
IA invasive ductal carcinoma of left breast that was found
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lumpectomy and adjuvant radiation therapy to whole left
breast and treated with Tamoxifen therapy. Screening
mammogram showed stable postoperative changes in left
breast with benign findings. The patient has been in remission for 2 years. She reported mid-low back pain, newonset skin lesions over bilateral palms, which appeared to
be whitish subcutaneous nodules over her palms for a
duration of 6 months. Review of systems, physical examination, and vital signs were otherwise unremarkable. Six
months prior, the patient had an episode of acute on chronic
left elbow olecranon bursitis that was confirmed by histopathology. Laboratory evaluation revealed as follows: cancer antigen (CA) levels were 27.29 units (reference =
0.0-38.6 units). Complete blood count, comprehensive
metabolic panel, serum phosphorous, serum magnesium,
serum uric acid, serum lactate dehydrogenase, serum 25
OH vitamin D, serum vitamin B12, and serum thyroid-stimulating hormone levels were within normal limits.
C-reactive protein was only minimally elevated at 7.1
mg/L (Ref. = 0-5 mg/L). Serum CA15 was within normal
limits at 17.3 units (Ref. = 0.0-25). Erythrocyte sedimentation rate was mildly elevated at 43 mm/h. Angiotensinconverting enzyme levels were noted to be in the normal
range at 29 U/L (Ref. = 14-82 U/L).
Magnetic resonance imaging (MRI) thoracic spine without
contrast was obtained to evaluate patient’s back pain. MRI
thoracic spine showed numerous clustered supraclavicular,
mediastinal, hilar, and upper abdominal lymph nodes suspicious for nodal metastases along with sub centimeter T1
hypointense right vertebral body lesions at T11 and L1, suspicious for bone metastases. MRI thoracic spine findings were
suspicious for malignancy and given the patient’s recent history of breast cancer, she underwent further evaluation by
positron emission tomography-computed tomography
(PET-CT). F-18 fludeoxyglucose (FDG) whole body PET-CT
demonstrated multiple significantly enlarged mediastinal
lymph nodes in the superior mediastinum, paratracheal
region, AP window, prevascular, and subcarinal regions.
There were multiple enlarged bilateral hilar, cardio phrenic
lymph nodes. Prominent lymphadenopathy was noted along
the peripancreatic, periportal, gastrohepatic ligament, retrocrural, splenic hilum, periaortic, mesenteric, left common
iliac, bilateral external iliac, and left internal iliac regions. A
focal splenic lesion measuring 1.5 cm with high normal
spleen size was noted. Multiple lung nodules measuring up to
1 cm in the left upper lobe were found. Bony lesions involving T11, L1 vertebral bodies, and pedicle of T1 vertebral body
were seen. These widespread lesions on PET-CT were highly
suspicious for lymphoma/metastasis. Hepatomegaly was
noted as well. As a result, the patient underwent single-photon emission computerized tomography (SPECT) of the thoracic and lumbar spine, which showed no scintigraphic
evidence of osteoblastic metastatic disease, no abnormal
uptake in the areas of increased FDG uptake involving the T1
spinous process, T11 or L1 vertebral bodies.
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As the patient was found to have diffuse lymphadenopathy from neck down to iliac chains with significant standardized uptake values (SUV) with increased activity at T11, L1
on PET-CT scan, she underwent multiple tissue biopsies.
Refer to Figures 3 to 12 for PET-CT and MRI thoracic
spine images.
Endobronchial biopsy of left lower lobe, bronchial
brushing of left upper lobe, bronchial washing, left hilar,
subcarinal, and right paratracheal samples showed no evidence of malignancy and reported as benign bronchial
mucosa with non-caseating granulomatous inflammation.
Refer to Figure 2 for the histopathological finding of the
noncaseating granuloma in our patient. Grocott-Gomori’s
(or Gömöri) methenamine silver stain, periodic acid–
Schiff stain were unremarkable. No fungal, acid-fast
microorganisms were noted on microscopy of lung tissue.
Morphological, histochemical, immunohistochemical, and
flow cytometric evaluation demonstrated no evidence of
malignancy in supraclavicular lymph node sample. The
patient also underwent T11 bone lesion biopsy with CT
guidance. Flow cytometric analysis of T11 vertebral bone
biopsy, transbronchial fine needle aspiration, and right
supraclavicular fine needle aspiration showed no significant lymphoid immunophenotypic abnormalities. Refer to
Figure 1 for a summary of diagnostic workup. The patient
was referred for rheumatologic evaluation in the interim,
which was deferred due to high suspicion of malignancy
given the widespread lymphadenopathy, history of breast
cancer until cleared by oncology. As sarcoidosis is a diagnosis of exclusion, our patient underwent extensive evaluation with multiple tissue biopsies to definitively rule out
malignancy, especially given the history of breast malignancy and presence of widespread radiographically suspicious lesions. As the patient was definitively excluded of
malignant disease with the tissue biopsy findings consistent with noncaseating granulomas and overall presentation with a history of olecranon bursitis, skin lesions on
palms, the patient was diagnosed with widespread sarcoidosis that was mimicking malignant disease. Based on overall clinical presentation and patient preference, the patient
was not started on steroids on confirmatory diagnosis. The
patient has been set up for further management of sarcoidosis and will be followed in an outpatient setting.

Discussion
Diagnosis of sarcoidosis requires compatible clinical and
radiographic manifestations, exclusion of other diseases with
similar presentation, and a histopathological evidence of
noncaseating granulomas.7,9,10 Diagnostic tissue sampling
should be obtained from the most accessible site of a suspected lesion such as lymph nodes or skin lesions with the
exception of erythema nodosum.8,10,11 For mediastinal lymph
node sampling, endobronchial ultrasound with nodal aspiration is the preferred initial method. Some infectious diseases
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Figure 1. Summary of diagnostic workup.

Figure 2. The characteristic pathologic lesion of sarcoidosis is
the non-necrotizing granuloma.

such as histoplasmosis or active tuberculosis can present
similar to sarcoidosis and hence exclusion of these causes is
required.8,11,12 PET scanning usually detects cells with high
metabolic activity and is helpful to differentiate pathologic
lymph nodes from the non-pathologic ones. Sarcoidosis often
causes positive PET results and thus, PET testing cannot differentiate sarcoidosis from lymphomas. Mediastinoscopy with

Figure 3. PET-CT demonstrating widespread lesions highly
suspicious for lymphoma/metastasis.

excisional biopsy is a second-line diagnostic method if endobronchial ultrasound with nodal aspiration does not confirm sarcoidosis (Table 2).7,9,13,14
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Figure 6. PET-CT demonstrating focal splenic lesion.

Figure 4. PET-CT demonstrating widespread lesions highly
suspicious for lymphoma/metastasis.

Figure 7. Widespread lesions on PET-CT highly suspicious for
lymphoma/metastasis.

Figure 5. Widespread lesions on PET-CT highly suspicious for
lymphoma/metastasis.

A majority of patients with sarcoidosis are expected to
have spontaneous remission in 2 years and hence usually do
not require any treatment. Patients are closely followed-up
with chest X-rays, pulmonary function tests, and clinical
evaluation.3,7,8,15,16 Corticosteroid therapy is used in patients
who have severe symptoms, hypercalcemia, neurologic or
cardiovascular or ocular involvement, and progressive pulmonary disease. If patients have refractory disease not

Figure 8. Widespread lesions on PET-CT highly suspicious for
lymphoma/metastasis.
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Figure 9. Widespread lesions on PET-CT highly suspicious for
lymphoma/metastasis.

Figure 12. MRI thoracic spine showing vertebral body lesions at
T11 and L1, suspicious for bone metastases.
Table 2. Diagnostic Studies for Sarcoidosis.1,3,5-8,17

Figure 10. Widespread lesions on PET-CT highly suspicious for
lymphoma/metastasis.

1. Chest X-ray may show adenopathy of hilar and paratracheal
nodes, parenchymal changes.
2. Laboratory evaluation findings include anemia, leukopenia,
abnormal liver function tests, hypercalcemia, and
hypercalciuria. Angiotensin-converting enzyme is elevated
in around 60% of patients with sarcoidosis although it is
nonspecific.
3. Pulmonary function tests may be normal or may show
restrictive or obstructive pattern.
4. Gallium-67 scan is helpful to localize areas of granulomatous
infiltrates.
5. Ophthalmologic examination is required in all patients with
suspected sarcoidosis and ocular findings, such as uveitis,
conjunctivitis, are common.
6. Biopsy is usually done on accessible tissues that are suspected
to have some quite involvement such as skin, lymph nodes.
Bronchoscopy with transbronchial biopsy is the procedure of
choice for those cases who do not have an easily accessible
site for biopsy.

responding to corticosteroids with progression, methotrexate
may be useful. Nonsteroidal anti-inflammatory agents are
used for erythema nodosum, arthralgias.4,7,8,14,17,18

Conclusion

Figure 11. MRI thoracic spine showing vertebral body lesions at
T11 and L1, suspicious for bone metastases.

Sarcoidosis is likely to give abnormal PET scan results and
would be difficult to differentiate malignant disease, lymphoma from sarcoidosis based on radiographic findings
alone. A diagnosis of sarcoidosis is made only after excluding all other possible similar presentations. Diagnosis of sarcoidosis may become difficult in scenarios where patient had
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a recent malignant disease and radiographic evaluation suggesting widespread suspicious disease. Tissue sampling with
a histopathological evidence of noncaseating granulomas
and exclusion of other causes is required to make a diagnosis
of sarcoidosis.
Our patient in this case had a history of breast cancer that
was treated with no previous diagnosis of sarcoidosis was
found to have widespread lesions on PET/CT imaging, MRI
imaging, and the findings on these radiological studies were
highly suspicious for malignancy. Multiple tissue biopsies
from suspicious lesions were negative for malignancy and
she was found to have granulomatous disease. Thus, it
becomes important to note that the lesions suspicious for
malignancy in radiological studies despite a history of cancer
may not always be metastatic or malignant disease and granulomatous disease can be a differential.
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